Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney F Minchin

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Biopolymers|May 17, 2008
The characterization of a novel dendritic system for gene delivery by isothermal titration calorimetryDaniel J Coles, Shu Yang, Rodney F Minchin, et al.
International Journal of Cancer|July 30, 2005
Concentration-dependent effects of N1, N11-diethylnorspermine on melanoma cell proliferationRodney F Minchin, Samuel Knight, Ajanthy Arulpragasam, et al.
Nanomedicine (London, England)|June 6, 2019
Drug formulation and nanomedicine approaches to targeting lymphatic cancer metastasesLili Wang, Christopher Subasic, Rodney F Minchin, et al.
The Biochemical Journal|August 30, 2003
Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1)Neville J Butcher, Ajanthy Arulpragasam, Catherine Pope, et al.
Molecular Pharmacology|June 24, 2010
Regulation of mouse brain-selective sulfotransferase sult4a1 by cAMP response element-binding protein and activating transcription factor-2Neville J Butcher, Deanne J Mitchell, Rachel Burow, et al.
The International Journal of Biochemistry & Cell Biology|March 6, 2019
Loss of human arylamine N-acetyltransferase I regulates mitochondrial function by inhibition of the pyruvate dehydrogenase complexLili Wang, Rodney F Minchin, Patricia J Essebier, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 10, 2024
A PEGylated liposomal formulation of prochlorperazine that limits brain exposure but retains dynamin II activity: A potential adjuvant therapy for cancer patients receiving chemotherapeutic mAbsChristopher N Subasic, Fiona Simpson, Rodney F Minchin, et al.
Cancer Letters|December 5, 2020
Hypoxia-mediated drug resistance in breast cancersCourtney E McAleese, Chandra Choudhury, Neville J Butcher, et al.
Biochemistry|June 15, 2023
Contrasting Effects of Temperature on Human Arylamine <i>N</i>-Acetyltransferase and Acetyl Coenzyme A Hydrolase ActivitiesChandra Choudhury, Courtney E McAleese, Neville J Butcher, et al.
Journal of Pharmaceutical Sciences|May 21, 2021
Monocytes Do Not Contribute to Sex Differences Seen in the Pharmacokinetics of Pegylated Liposomal DoxorubicinLili Wang, Neville J Butcher, Rodney F Minchin, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Biopolymers|May 17, 2008
The characterization of a novel dendritic system for gene delivery by isothermal titration calorimetryDaniel J Coles, Shu Yang, Rodney F Minchin, et al.
International Journal of Cancer|July 30, 2005
Concentration-dependent effects of N1, N11-diethylnorspermine on melanoma cell proliferationRodney F Minchin, Samuel Knight, Ajanthy Arulpragasam, et al.
Nanomedicine (London, England)|June 6, 2019
Drug formulation and nanomedicine approaches to targeting lymphatic cancer metastasesLili Wang, Christopher Subasic, Rodney F Minchin, et al.
The Biochemical Journal|August 30, 2003
Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1)Neville J Butcher, Ajanthy Arulpragasam, Catherine Pope, et al.
Molecular Pharmacology|June 24, 2010
Regulation of mouse brain-selective sulfotransferase sult4a1 by cAMP response element-binding protein and activating transcription factor-2Neville J Butcher, Deanne J Mitchell, Rachel Burow, et al.
The International Journal of Biochemistry & Cell Biology|March 6, 2019
Loss of human arylamine N-acetyltransferase I regulates mitochondrial function by inhibition of the pyruvate dehydrogenase complexLili Wang, Rodney F Minchin, Patricia J Essebier, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 10, 2024
A PEGylated liposomal formulation of prochlorperazine that limits brain exposure but retains dynamin II activity: A potential adjuvant therapy for cancer patients receiving chemotherapeutic mAbsChristopher N Subasic, Fiona Simpson, Rodney F Minchin, et al.
Cancer Letters|December 5, 2020
Hypoxia-mediated drug resistance in breast cancersCourtney E McAleese, Chandra Choudhury, Neville J Butcher, et al.
Biochemistry|June 15, 2023
Contrasting Effects of Temperature on Human Arylamine <i>N</i>-Acetyltransferase and Acetyl Coenzyme A Hydrolase ActivitiesChandra Choudhury, Courtney E McAleese, Neville J Butcher, et al.
Journal of Pharmaceutical Sciences|May 21, 2021
Monocytes Do Not Contribute to Sex Differences Seen in the Pharmacokinetics of Pegylated Liposomal DoxorubicinLili Wang, Neville J Butcher, Rodney F Minchin, et al.
Pageof 8